The Implications of Medical Device Labeling

TASA ID: 248

On October 7, 2014, The TASA Group in conjunction with medical device expert, Dr. Edward Reese presented a free, one-hour, interactive webinar presentation, The Implications of Medical Device Labeling, for all legal professionals.

This webinar discussed the implications of medical device labeling that could contribute to, or directly cause, a patient serious injury or death. Dr. Reese provided information about the established laws and regulations that govern device-labeling requirements. He also discussed commercial distribution, as well as Design Objective Intent.

About the Presenter:

Dr. Edward Reese has more than 30 years of industry experience. He has been involved in the design, development, manufacture, and quality control of medical devices. Dr. Reese is responsible for the design and implementation of corporate policies and procedures for medical products. He also provides litigation support services for cases involving medical devices. Dr. Reese is a Medical Device FDA Regulations/Manufacturer Liability expert. He has also provided testimony for deposition and/or trial for more than 20 years.